Olschewski, Daniel Navin
Nazarzadeh, Nilufar
Lange, Felix
Koenig, Anna Maria
Kulka, Christina
Abraham, Jella-Andrea
Blaschke, Stefan Johannes
Merkel, Rudolf
Hoffmann, Bernd
Fink, Gereon Rudolf
Schroeter, Michael
Rueger, Maria Adele
Vay, Sabine Ulrike
Funding for this research was provided by:
Gerok Program (3622/9900/11, 3622/9900/11)
Köln Fortune Program (326/2020, 370/2019)
Cologne Clinician Scientist Program (773/15-1)
Deutsche Forschungsgemeinschaft (431549029 – SFB 1451, 431549029 – SFB 1451, 431549029 – SFB 1451)
Marga und Walter Boll-Stiftung (210-10-15, 210-10-15, 210-10-15)
Universitätsklinikum Köln
Article History
Received: 4 August 2023
Accepted: 13 June 2024
First Online: 26 June 2024
Declarations
:
: All animal procedures were carried out according to the German Laws for Animal Protection. The local animal care committee (Tierschutz-Beauftragte University of Cologne) and governmental authorities (AZ UniKöln_Anzeige §4.16.021; Animal testing license: 84-02.04.2015.A173, LANUV NRW, Germany) had approved the study. Consent to participate is not applicable as no human participants, human tissue or human data were involved in the study.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.